We have recently reported that neoplastic transformation of two rat thyroid epithelial cell lines by retroviruses carrying the v-mos and v-ras Ki oncogenes is associated with a drastic increase of AP-1 activity. The most important eects were represented by the dramatic junB and fra-1 gene induction, which was abolished by the block of the transformation-induced HMGI-C protein synthesis. Here, we have further characterized the transformation-dependent AP-1 activity, by analysing the expression of dierent jun-and fos-related components, in rat thyroid cell lines transformed by several oncogenes, in human thyroid carcinoma cell lines, and in naturally occurring human thyroid tumours. A signi®cant increase of Fra-1 and JunB protein levels was detected in all oncogene transformed rat thyroid cell lines. Fra-1 gene induction was demonstrated to occur also in human thyroid carcinoma cell lines and tissues. Conversely, cJun and JunD proteins, rather than JunB, accumulated in human thyroid carcinoma cell lines. An induction of AP-1 target genes was also detected both in rat and human thyroid transformed cell lines. Therefore, in vivo and in vitro thyroid cell transformation is associated with important compositional changes in the AP-1 complex and an increased transcriptional activity.
Introduction
The AP-1 complex is formed by three Jun-family members (c-Jun, JunB and JunD) and four Fos-family members (c-Fos, FosB, Fra-1 and Fra-2), giving rise to a large variety of homo-and hetero-dimers binding to the same DNA consensus sequence, and are responsible for the activation of various target genes involved in the control of cell proliferation, tumorigenesis and metastasis (Angel and Karin, 1991; Karin et al., 1997) . A causal role of AP-1 in neoplastic transformation has been demonstrated: a dominant negative c-Jun is able to suppress the ras-mediated transformation (Lloyd et al., 1991; Granger-Schnarr et al., 1992; Brown et al., 1993) . Subsequent approaches were aimed at understanding the role of the individual AP-1 components in the transformation of mouse 3T3 (Suzuki et al., 1994; Pfarr et al., 1994; Mechta et al., 1997) and rat embryo ®broblasts (Vandel et al., 1996) . In addition, it has been reported that cell lines established from c-jun knock out mice are resistant to ras-mediated transformation (Johnson et al., 1996) . As far as the role of the AP-1 components in the transformation of epithelial cells is concerned, several studies indicate that an increased AP-1 activity, often associated with c-jun modi®cations, is a necessary event in the transformation of mouse epidermal cells (Domann et al., 1994; Dong et al., 1994 Dong et al., , 1997 Rosenberger and Bowden, 1996; Li et al., 1996; Joselo and Bowden, 1997) . However, since epithelial cells represent the cell type most frequently involved in human solid tumours, more information about the role and modi®cations of AP-1 in epithelial cell transformation is required.
We have recently characterized the transformationdependent modi®cations of AP-1 activity in two rat thyroid cell lines, FRTL-5 and PC Cl 3, transformed by the Kirsten Murine Sarcoma virus (Ki-MSV) and the Myeloproliferative sarcoma virus (MPSV) carrying the v-ras-Ki and v-mos oncogenes, respectively. We have shown that the drastic increase of AP-1 activity re¯ects multiple compositional changes (Vallone et al., 1997) . In particular, we have shown that the transformation-dependent accumulation of JunB and Fra-1 proteins results from strong gene induction, while the accumulation of the two other Jun-related components (c-Jun and JunD) takes place independently from changes at the mRNA level. In addition, we have shown that the block of the HMGI-C protein synthesis, which inhibits the establishment of the fully transformed phenotype, also prevents the accumulation of the Fra-1 protein and the three Jun-related components. Since HMGI (Y) protein-induction is blocked in retrovirally infected cells carrying the HMGI-C antisense construct , the inhibitory eects on Fra-1 and Jun proteins can also be attributed to the absence of the HMGI (Y) proteins. Finally, we have shown that the fra-1 gene activation is a necessary event in thyroid cell transformation, since a block of its synthesis, by stable expression of a fra-1 antisense-RNA, signifi-cantly reduces the malignant phenotype of the rat thyroid transformed cells (Vallone et al., 1997) .
The aim of this work is to investigate whether the previously described AP-1 increased activity, due to Fra-1 and jun protein induction, is a general event in thyroid cell transformation.
First, we analysed the AP-1 activity and composition in a series of PC Cl 3 and FRTL-Cl 2-derived rat thyroid cell lines transformed by several viral oncogenes. In all of them, we observed an increased AP-1 activity related to the accumulation of Fra-1 and JunB proteins. Subsequently, several human thyroid carcinoma cell lines, and tissues were analysed. All the human thyroid carcinoma cell lines expressed Fra-1 protein, which was, in contrast, not detected in normal thyroid cells. Both c-Jun and JunD proteins, but not JunB, were found increased in human thyroid transformed cells. The analysis of the AP-1 target gene expression showed that the observed compositional changes were associated with an increased AP-1 transcriptional activity. In particular, the collagenase gene, was found to be strongly induced both in rat and in human thyroid carcinoma cell lines. Finally, immunohistochemical analysis of paran embedded tissues showed the presence of the Fra-1 protein in human thyroid carcinomas, but not in normal thyroid, suggesting that Fra-1 induction is a general event in thyroid cell transformation both in vitro and in vivo.
Results

AP-1 activity is increased in transformed rat thyroid cell lines
The AP-1 in vitro binding activity in a series of cell lines derived from the dierentiated rat thyroid cells (PC Cl 3 and FRTL-5 Cl 2) infected by retroviral vectors expressing dierent oncogenes was investigated. It has been previously shown that the transformation of rat thyroid cells results in a wide variety of phenotypes, ranging from the undierentiated nontumorigenic cell lines, such as PC v-raf, PC v-abl, PC v-ras-Ha, PC v-src, PC v-ras-Ki, to the highly malignant lines, such as PC MPSV, FRTL KiMSV, PC E1A+v-raf, FRTL v-ras-Ha and FRTL v-src through the PC PyMLV cell line, showing a partially dierentiated phenotype associated with a low tumorigenic phenotype (Fusco et al., 1987; Berlingieri et al., 1988 Berlingieri et al., , 1993 . The characteristics of these cell lines are summarized in Table 1 .
The in vitro binding to the CollTRE oligonucleotide was increased in all of the oncogene transformed cell lines. The highest increase of AP-1 activity was observed in the PC MPSV, PC v-abl, PC E1A+v-abl, PC E1A+v-raf, PC HaMSV cells (Figure 1a lanes 3 , 5, 6, 8, 9 and 10) . The other cell lines exhibited an intermediate increase, with the exception of the partially dierentiated PC PyMLV showing a small increase in the AP-1 binding activity (Figure 1, lane 7) .
The binding activity of the dierent nuclear extracts was normalized by using an oligonucleotide probe binding the ubiquitous Sp1 transcription factor ( Figure  1b) .
Increased JunB and Fra-1 protein levels in rat thyroid transformed cells
To characterize the regulatory changes associated with the increase of AP-1 binding activity, we analysed the protein levels of the AP-1 components. Immunoblotting analysis showed a dramatic Fra-1 induction in all the oncogene-expressing cells. A small induction was observed in the FRTL v-src cells (Figure 2 , lane 15), whereas no induction was present in the PC PyMLV cells (Figure 2 , lane 6). The Fra-1 immunodetection resulted in the appearance of multiple bands, which have been previously described as phosphorylation products . The Fra-1 increase mainly in oncogene-expressing cells aected the slowermigrating component (Figure 2) .
No signi®cant quantitative changes were observed for the other Fos-related AP-1 components, c-Fos, Fos-B and Fra-2 (data not shown) apart from the overexpression of the FosB gene in the FRTL-KiMSV cells, as previously demonstrated (Vallone et al., 1997) .
We then examined the expression of the Jun-related components. Western blot analysis con®rmed our previous results, showing that the 38 kDa JunB polypeptide, essentially undetectable in the exponentially growing normal thyroid cells, was dramatically increased in the PC MPSV and FRTL-KiMSV cells. We detected a variable degree of JunB accumulation in the other cell lines, and only a slight increase in the PC 
b Tumorigenicity was assayed by injecting 2610 6 cells into nude mice Immunoblotting analysis with the JunD-selective antibodies allowed to detect the previously described doublet of 41 kDa and 37 kDa, both representing JunD-speci®c protein products. The expression of JunD, already detectable in proliferating normal thyroid cell lines, was clearly increased without signi®cant variations in all the oncogene-expressing cells except for the PC E1A and FRTL v-src where only a weak increase was observed.
The expression pattern of the p39 c-Jun polypeptide was rather complex, showing a considerably increased level in the PC MPSV, PC E1A, PC E1A+v-abl, PC v-src and FRTL-KiMSV cells (Figure 2 , lanes 2, 4, 7, 11 and 13, respectively), and little or no accumulation in the other cell lines. The immunoblotting results were normalized by re-incubation of the Western blots with Sp1 selective antibodies, allowing to verify the equal loading of the nuclear protein samples ( Figure  2 ). In summary, while the level of Fra-1 expression shows a certain correlation with the transformed phenotype, the expression pattern of the Jun family members appears rather complex.
Fra-1 and junB induction occurs at mRNA level Northern blot analysis was performed to investigate whether the oncogene-dependent increase of the Fra-1 and JunB proteins was consequent to changes at the mRNA level. The results of Figure 3 , show that fra-1 and junB transcripts were increased in most of the transformed cell lines suggesting a transcriptional activation. However, since the fra-1 and junB mRNA levels did not perfectly parallel protein levels, additional regulatory mechanisms at the protein level must be taken in consideration. In agreement with immunoblotting results the fra-1 and junB mRNAs were not signi®cantly increased in the PC PyMLV cells (as shown in Figure 3 , lane 6).
The hybridization to the junD-speci®c probe did not reveal, for all the cell lines, signi®cant dierences at the mRNA level, in agreement with the results previously obtained for the PC MPSV and FRTL KiMSV, suggesting a control at the protein level (data not shown). Similarly, the Northern blot analysis showed small variation (up to threefold) of the c-jun mRNA in all the cell lines (data not shown). Again, the changes at the protein level cannot be explained by the variations of the c-jun mRNA level.
AP-1 target genes are only expressed in transformed rat thyroid cell lines
To determine the functional consequences of the increased AP-1 complex we examined the expression of the prototype AP-1 target gene involved in the transformed phenotype, the type 1 collagenase, which plays an important role in the degradation of extracellular matrix. As shown in Figure 4 , the collagenase mRNA, undetectable in the normal cell lines, was dramatically induced in all of the transformed rat thyroid cell lines. Interestingly, the PC PyMLV cell line showed, at the same time, a slight increase in AP-1 activity, in fra-1 gene induction and in the expression of the collagenase gene ( Figure 3 , lane 7). Similar results were obtained analysing the expression of another AP-1 target gene, the Vascular Endothelial Growth Factor-VEGF (data not shown), an angiogenic growth factor often activated in experimental and human neoplasias. Conversely, no increased expression was observed for the histone H2b gene regulated by the ubiquitous Oct-1 transcriptional factor (Sittman et al., 1983; Tanaka and Herr, 1990) (Figure 4) . Moreover, as already demonstrated for the FRTL-KiMSV and PC MPSV cell lines (Vallone et al., 1997) , activation of a transiently transfected AP-1 reporter construct also occurs in other transformed cell lines analysed (data not shown).
The AP-1 activity is increased also in human thyroid carcinoma cell lines
To investigate whether AP-1 increased activity was also a feature of human transformed thyroid cells, ®ve thyroid carcinoma cell lines (two derived from papillary carcinomas: NPA and TPC-1, two from anaplastic carcinomas FRO and ARO, and one from a follicular thyroid carcinoma, WRO), were ®rst analysed for the AP-1 binding activity. The results, shown in Figure 5a , demonstrate that in all the carcinoma cell lines there is an increase in AP-1 binding activity compared to the normal human thyroid cell culture, HTC 2, kept in culture for 30 passages. The binding activity of the nuclear extracts from these cell lines was normalized using an oligonucleotide probe binding to the ubiquitous Sp1 transcription factor (Figure 5b ). The AP-1 in vivo activity was evaluated analysing the expression of the type 1 collagenase gene. The results obtained by RT ± PCR analysis, shown in Figure 6 , were in agreement with the increased collTRE binding activity in the carcinoma cells. Accordingly, the TPC-1 cell line which presents a weak DNA binding activity and a low expression level of the fra-1 gene (see next Figure 8 ), shows a very low expression of the collagenase gene. In fact, it can be detected in these cells only increasing the number of cycles of RT ± PCR ampli®cation (data not shown). However no collagenase gene expression was observed in the normal thyroid cells in the same conditions (data not shown). A very high collagenase gene expression was observed in the anaplastic cell line FRO (lane 6). Analogous results were published by our group investigating the VEGF gene (Viglietto et al., 1995) . No increased expression was observed for the histone H2b (Figure 6 ).
Fra-1, c-Jun and JunD protein accumulation in human thyroid carcinoma cell lines
Immunoblotting analysis using anti Fra-1 antibodies showed its accumulation in carcinoma cell lines ( Figure  7 ), but not in normal cells (Figure 7 , lane 1), where it was almost undetectable. Interestingly, the TPC 1 (Figure 7 , lane 2) cells express low levels of the most phosphorylated form of Fra-1 (indicated by an arrow), very abundant in the other carcinoma cell lines. RT ± PCR analysis, Figure 8 , showed a clear correlation between Fra-1 protein and mRNA level indicating that the induction of this gene in transformed cells is likely to be a transcriptional event.
To further investigate the AP-1 changes in human thyroid carcinomas cells, we analysed the protein and mRNA level of the main AP-1 components. Western blot analysis showed a high increase of the jun family elements. In particular, JunD 41/37 kD polypeptides were present in all the carcinoma cell lines, whereas they were not detected in HTC 2 cells. Analogous data were obtained analysing the levels of c-Jun (Figure 7) . In fact, a signi®cant amount of c-Jun protein was observed in carcinoma cell lines, but not in normal thyroid cells. Conversely, the JunB protein, although constantly increased in rat thyroid transformed cells, was not detectable in normal and transformed human thyroid cells (data not shown). These data suggest that JunD and c-Jun proteins represent the major jun related components expressed in human thyroid carcinoma cells. RT ± PCR analysis, shown in Figure  8 , demonstrates that increased levels of c-jun and junD speci®c transcripts occur in thyroid carcinoma cell lines. However, there is no obvious correlation between the RNA and protein levels con®rming, also in human thyroid system, that the accumulation of the Jun related proteins in transformed cells dependent on post-translational modi®cations.
Immunohistochemical analysis of the Fra-1 protein in human thyroid carcinomas Surgically removed thyroid neoplasias were investigated by immunohistochemistry using antibodies versus a Fra-1 speci®c peptide. The technique was set up analysing Fra-1 protein in the FRO cells and in tumors induced by the inoculation of these cells into athymic mice (data not shown). Fra-1 protein was detected in all of the human thryoid carcinomas analysed (12 papillary and four follicular thyroid carcinomas). In contrast, no staining was observed in four normal thyroid tissues. An example of the immunostaining performed with anti-Fra-1 antibodies is shown in Figure 9 ; a clear nuclear staining was observed in carcinomas (Figure 9b and c) . A weak cytoplasmic staining was also observed in these tissues. No immunoreactivity was detected in normal thyroid tissue (Figure 9a ). The speci®city of the reaction was demonstrated by pre-incubating the Fra-1 speci®c antibodies with a Fra-1 peptide (Figure 9d ). RT ± PCR analysis of the fra-1 gene expression con®rmed the data obtained by immumohistochemistry (data not shown). Preliminary data indicate that staining with antibodies versus junD and c-jun proteins is speci®c for thyroid carcinomas, but not for normal thyroid (data not shown).
Discussion
Several recent reports have addressed the role of AP-1 compositional changes in oncogenic transformation; all these studies, however, were based on ®broblast-derived (mouse, rat or chicken) cell lines (Pfarr et al., 1994; Mechta et al., 1997; Suzuki et al., 1994) .
Because of the few available experimental systems, the molecular mechanisms of epithelial transformation are much less characterized, although the vast majority of the human solid tumors have an epithelial origin. Thyroid cell lines represent a useful model system for studying epithelial tumorigenesis, allowing to dissect the mechanisms of interference between transformation and dierentiation.
We have recently characterized the transformationdependent AP-1 compositional changes in two dierent rat thyroid cell lines (PC Cl 3 and FRTL-5 Cl 2) and shown the essential role played by fra-1 gene, (Cohen and Curran, 1988) and to a lower extent by junB, in the establishment of the transformed phenotype (Vallone et al., 1997) .
Here, we have analysed in detail the AP-1 activity and composition in the same rat thyroid cells transformed by dierent oncogenes, and in human thyroid carcinoma cell lines. The comparison between the various in vitro transformed cell lines shows that the AP-1 activity is increased by the expression of all of the analysed oncogenes, except for mT-Py. Since the PC PyMLV cells retain most of dierentiated thyroid properties, a possible role of the AP-1 overexpression in the extinction of the thyroid-speci®c markers might be suggested. Even though the most highly tumorigenic cell lines exhibit a very large increase of AP-1, a clear correlation between the AP-1 activity and the degree of the malignancy was not found. In fact, the non tumorigenic PC HaMSV and PC v-abl cells showed higher AP-1 activity compared to the FRTL-5 v-src cells showing a highly neoplastic phenotype. It is reasonable that, even though AP-1 changes play an important role in the acquisition of neoplastic phenotype, the degree of malignancy is given by the Figure 8 Expression of Fra-1, junD and c-jun mRNA in normal and human thyroid carcinoma cell lines. RT ± PCR was performed using 0.5 mg of total mRNA using fra-1, junD and c-jun speci®c primers. The cDNAs were co-ampli®ed with GAPDH speci®c primers as internal control. Southern blots of the ampli®ed products were hybridized to the Fra-1 and junD and c-jun radiolabelled cDNAs, and then with a GAPDH, as a The increased AP-1 activity in rat thyroid cells is associated with the accumulation of the Fra-1 and JunD proteins. The fra-1 gene induction occurs, mainly, at the mRNA levels since fra-1 mRNA speci®c transcripts were increased in almost all of the transformed cells. It is interesting to note that the AP-1 in vitro binding activity does not tightly correlate with the level of the fra-1 gene expression. The lack of correlation might re¯ect quantitative and/or qualitative dierences of the phosphorylation of Fra-1, and possibly of other AP-1 components, which has been shown to aect the DNA binding activity of the AP-1 complex (Gruda et al., 1994; Papavassiliou et al., 1995) . Our analysis shows that while the JunD accumulation is a rather general event among the oncogene-expressing cell lines (with the exception of the PC E1A), the increase of JunB and c-Jun seems to be more restricted. Therefore, these two components are not always co-regulated. For instance, JunB is signi®cantly accumulated in the PC v-abl cell line, where the c-Jun level is essentially comparable to the parental PC Cl 3 cells, while the c-Jun level is increased in the E1A-expressing cell lines, where there is no signi®cant JunB accumulation (the latter result likely re¯ects the well documented transcriptional induction of the c-jun promoter by the E1A gene product (Hegmayer et al., 1993) . The mRNA analysis of the jun-family members revealed that, dierently from junB, the increased level of the c-Jun and JunD proteins does not re¯ect quantitative changes of the transcripts, con®rming and expanding our previous observation on the PC MPSV and FRTL KiMSV cell lines (Vallone et al., 1997) . Accordingly, we have recently shown that the half-life of both c-Jun and JunD is signi®cantly increased in the transformed cell lines, thus confirming the hypothesis of a post-translational control of the protein level (manuscript in preparation).
The extension of our study to the human thyroid carcinoma cell lines allowed to detect a consistent increase of the AP-1 activity, compared to normal thyroid cells. Surprisingly, the analysis of the individual components revealed that the increaed AP-1 in vitro activity is associated with increased levels of Fra-1, cJun and JunD proteins, but not JunB. It can be hypothesized that some species-speci®c mechanism might aect the transformation-dependence of individual AP-1 components; such mechanism might explain, for instance, the increased expression of fra-2, rather than fra-1, in chick embryo ®broblasts transformed by dierent oncogenes (Suzuki et al., 1994) .
The analysis of the prototype AP-1 target gene revealed that the collagenase mRNA, undetectable in normal human thyroid cells, is accumulated in human thyroid carcinomas and in in vitro transformed rat thyroid cells, except for those expressing the Py-mT.
The level of the collagenase transcript qualitatively re¯ects the AP-1 activity. The absence of a tight quantitative correlation between the collagenase mRNA expression and the AP-1 in vitro activity (collTRE binding) might re¯ect additional regulatory levels, such as the eect of post-transcriptional mechanisms (i.e. mRNA stability) and post-translational modi®cations, dierently aecting the transactivation eciency of the AP-1 complex in each of the analysed cell lines. In addition, the collagenase promoter, similarly to other transcriptional targets of nuclear oncogenes, has been shown to depend on the ets/AP-1 cooperative activity (Gutman and Wasylyk, 1990) . Accordingly, we have recently characterized the induction of the ets-family components, both in vitro transformed and in human carcinoma cell lines (de Nigris et al., manuscript in preparation).
An important issue is represented by the mechanism of fra-1 activation during the establishment of the transformed phenotype. Since the fra-1 promoter has been identi®ed as a transcriptional target of c-Fos, we have proposed that the transient induction of c-fos could be responsible for the irreversible activation of fra-1, during the early steps of transformation (Vallone et al., 1997) . By the use of the two step skin tumorigenesis experimental model, it has been shown that the c-fos knock out mice can normally develop papillomas, but these tumors are unable to progress to skin carcinomas, and show a lack of induction of the AP-1 target genes (Saez et al., 1995) . Therefore, it will be important to investigate whether the experimental thyroid tumor induction would be blocked in the c-fos knock out mice. As far as the role of Fra-1 in thyroid cells transformation is concerned, we must underline that even though Fra-1 overexpression is able to induce morphological transformation, but not anchorage independency, of rat ®broblasts (Bergers et al., 1995) , and is required for thyroid cell transformation (Vallone et al., 1997) , however it is not able to induce mor-phological or tumorigenic eect on rat thyroid cells. These results, indicate that Fra-1 overexpression is necessary but not sucient for thyroid cell transformation.
Taken together, our results strongly indicate that the increased AP-1 activity is a general event in epithelial transformation and re¯ects the complex functional relationship between dimeric composition, post-translational modi®cation and in vivo AP-1 activity. Independently by the complexity of the regulatory interactions, our analysis con®rms the role of fra-1 gene overexpression, not only in the in vitro transformations, but also in human thyroid tumorigenesis. On this basis, the immunohistochemical analysis of the Fra-1 protein might represent a useful tool in the diagnosis of thyroid neoplastic diseases. Finally, it can be speculated that the in vivo selective inhibition of fra-1 expression might be utilized to attenuate the neoplastic phenotype, as previously shown by our in vitro functional analysis (Vallone et al., 1997) .
Materials and methods
Cell cultures
PC Cl 3 rat thyroid cells are derived from 18 months old and FRTL5 Cl2 cells from 3 ± 4 weeks old Fisher rats (Berlingieri et al., 1988; Fusco et al., 1987) . The PC Cl 3 and FRTL5 Cl2 transformed cell lines have been previously described (Fusco et al., 1987; Berlingieri et al., 1993; Santoro et al., 1993) . They were grown in Coon's modi®ed Ham's F12 medium supplemented with 5% calf serum (Gibco Laboratories) and six growth factors (1610 710 M TSH, 10 mg/ml insulin, 1610 78 M hydrocortisone, 5 mg/ml human transferrin, 10 ng/ml somatostatin, 10 ng/ml glycil-L-Histidil-L-lysine acetate). The human thyroid carcinoma cell lines (TPC-1, NPA, WRO, ARO and FRO) have been described  AP1 activity and thyroid cell transformation S Battista et al Cerutti et al., 1996) . They were grown in DMEM plus 10% fetal calf serum. HTC-2 cells were established and cultured as described (Curcio et al., 1994) .
Nuclear extract preparation
Cells were washed twice in phosphate-buered saline (PBS) and resuspended in 10 volumes of a solution containing 10 mM HEPES pH 7.9, 10 mM KCl, 1.5 mM MgCl 2 , 0.1 mM EGTA, 0.5 mM DTT (homogenization solution). The cells were disrupted by passage through a 26 gauge needle. Nuclei were collected by centrifugation at 1500 r.p.m. and resuspended in a 1.2 volumes of extraction solution containing 10 mM HEPES pH 7.9, 0.4 M NaCl, 1.5 mM MgCl 2 , 0.1 mM EGTA, 0.5 mM DTT, 5% glycerol, to allow elution of nuclear proteins by gentle shaking at 48C. Nuclei were pelleted again by centrifugation at 12 000 r.p.m. and the supernatant was stored at 7708C until use. The protease inhibitors leupeptin (5 mM), aprotinin (1.5 mM), phenylethylsulfuniluoride (2 mM), peptastatin A (3 mM, benzamidine (1 mM) were added to both homogenization and extraction solutions. Protein concentration was determined by the Bradford protein assay (BioRad).
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts (2.5 ± 5 mg of proteins) were incubated in 20 mM HEPES pH 7.5, 40 mM KCl, 5% Glicerol in a volume of 20 ml containing 1 mg poly(dI-dC) and 5 mM spermidine, for 10 min at room temperature. Binding reactions were incubated for others 15 min after the probe addition. The sequences of the oligonucleotide probes were: AP-1 (TRE of human collagenase promoter, collTRE) 5'-TTCCGGCTGACTCATCAAGCG-3'; Lee et al. (1987) . Sp1 consensus binding sequence 5'-ATTC-GATCGGGGCGGGGCGAGC-3' Briggs et al. (1986) . Samples were then separated on 8% native polyacrylamide gels (acrylamide : bis 29 : 1 in 0.56TBE).
Immunoblotting analysis
The nuclear extracts separated by 9% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS ± PAGE) were transferred to Immoblon-P Transfer membranes (Millipore). Membranes were blocked with 5% nonfat milk proteins and incubated with antibodies at a dilution of 1 : 5000. Bound antibodies were detected by the appropriate horseradish perosidase-conjugated secondary antibodies followed by enhanced chemiluminescence (ECL; Amersham). To ascertain that equal amounts of protein lysates were loaded, a parallel gel was loaded and stained with Poinceau. Moreover the same Western blots were incubated with antibodies versus the Sp1 protein. All the lanes showed a band of the same intensity. The anti-c-Jun/AP-1 (N), anti JunB (N-17), anti JunD (329) and anti Fra-1 (N-17) were purchased from Santa Crutz, Biotechnology (USA).
RNA extraction and Northern analysis
Total RNA was extracted by using the guanidine thiocyanate method (Chomczynski and Sacchi, 1987) . Northern blots and hybridizations were carried out following a started procedure (Sambrook et al., 1989) . cDNA probes were labeled with [a 32 P]dCTP using the random oligonucleotide primer (Ready-To-Go, Pharmacia) to a speci®c activity equal to or higher than 7610 8 c.p.m./ mg. The probes used were: a 1.0 kb HindIII ± XbaI fragment corresponding to the cDNA of the mouse c-jun gene (De Cesare et al., 1995) ; a 1.7 kb EcoRI ± EcoRI fragment corresponding to the cDNA of the mouse junD gene (Hirai et al., 1989) ; a 1.55 kb EcoRI ± EcoRI fragment corresponding to the cDNA of the mouse junB gene (Ryder et al., 1988) ; a 1.5 kb EcoRI ± EcoRI fragment corresponding to the cDNA of the rat fra-1 gene (Cohen and Curran, 1988) ; a 0.4 kb EcoRI ± HindIII fragment corresponding to the cDNA of the human GAPDH (glyceraldehy-de 3-phosphate dehydrogenase).
Reverse transcriptase-PCR (RT ± PCR) analysis
Five mg of total RNA, digested with DNAse, were reverse transcribed using random exonucleotides as primers (100 mM) and 12 units AMV reverse transcriptase (Promega). 0.2 mg of cDNA were ampli®ed in a 25 ml reaction mixture containing 0.2 mM dNTPs, 1.5 mM MgCl 2 , 0.4 mM of each primer, 1 unit Taq DNA polymerase (Perkin-Elmer). For the type 1 collagenase after a ®rst denaturing step (958C for 2 min), PCR ampli®caiton was performed for 30 cycles (958C for 1 min, 458C for 30 s, 728C for 30 s). Sequences (5'-3') of oligonucleotide forward and reverse primers used for ampli®cation of speci®c cDNAs were: 5'-TTGGCGG-GGACGCCCATTTTGATGATGA-3' and 5'-AGACAG-CATCTACTTTGTCGCCAATTCCAGG-3'
(nucleotides 570 ± 601 and 1259 ± 1290, respectively) (Gack et al., 1994) . For the fra-1, c-jun and junD cDNAs the PCR ampli®cation were performed for 20 cycles (958C for 1 min, 508C for 30 s, 728C for 30 s) in presence of the speci®c primers for fra-1: forward 5'-GTCATTGCTAGGATAC-CAAAC-3'); reverse 5'-CACTGTCCAGCAAGGGTCT-GT-3', corresponding to the nucleotides 136 ± 156 and 335 ± 315, respectively . The speci®c primers for c-jun were: forward 5'-CAGCGGAGCAT-TACCTCATC-3' and reverse 5'-GTGCAACTCTGAGC-CCTTAT-3', corresponding to the nucleotides 87 ± 107 and 296 ± 276, respectively (Hattori et al., 1988) . The speci®c primers for junD were: forward 5'-TGGAGGATTTACA-CAAGCAG-3' and reverse 5'-CGTCTGTGGCTTTCG-TCCTTGA-3' corresponding to the nucleotides 301 ± 321 and 605 ± 585, respectively . Expression of the GAPDH gene was used as an internal control. The speci®c primers were: forward 5'-ACATGTTCCAA-TATGATTCC-3' and reverse 5'-TGGACTCCACGACG-TACTCA-3' coresponding to the nucleotides 195 ± 215 and 355 ± 335) respectively (Tokunaga et al., 1987) . The speci®c primers for H2B were: forward 5'-CCCTCTAAGTC-TGCTCCAGC-3' and reverse 5'-GAGCGCTTATTGTA-GTGAGC-3', corresponding to the nucleotides 368 ± 388 and 620 ± 600, respectively (Kardalinou et al., 1993) .
Immunohistochemistry 4 ± 8 mm thick frozen sections of normal and pathological tissues were cut in a frozen microtome and allowed to dry for 1 h at room temperature (RT), before ®xing in acetone for 10 min. The slides were air dried for 2 h at RT and then placed in a buer bath (PBS) for 5 min before the immunoperoxidase staining procedure.
For the immunohistochemical studies of paran embedded samples, 3 ± 4 mm paran sections were deparaned and then placed in a solution of absolute methanol and 0.3% hydrogen peroxide for 30 min and then washed in PBS before immunoperoxidase staining.
The anitbodies used were the Fra-1 (R20) rabbit polyclonal antibodies reacting versus amino acids 3 ± 22 mapping at the amino terminus of Fra-1 of human origin and were purchased from Santa Crutz, Biotechnology (USA).
The slides were then incubated overnight at 48C in a humidi®ed chamber with the antibodies diluted 1 : 1000 in PBS. The slides were subsequently incubated with Biotinylated goat anti-rabbit IgG for 20 min (Vectostain ABC kits, Vector Laboratories) and then with premixed reagent ABC (Vector) for 20 min. The immunostaining was performed by AP1 activity and thyroid cell transformation S Battista et al incubating the slides in diaminobenzidine (DAB-DAKO) solution containing 0.06 mM DAB and 2 mM hydrogen peroxidase in 0.05% PBS pH 7.6 for 5 min and after chromogen development, the slides were washed, dehydrated with alcohol and xylene, and mounted with coverslips using a permanent mounting medium (Permount). Micrographs were taken on Kodak Ektachrome ®lm with a photo Zeiss system.
